Pacira BioSciences' Change in Inventory rose 12.89% to $9.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.8 million, marking a year-over-year increase of 198.48%. This contributed to the annual value of $20.9 million for FY2024, which is 152.46% up from last year.
As of Q3 2025, Pacira BioSciences' Change in Inventory stood at $9.5 million, which was down 33.93% from $14.4 million recorded in Q2 2025.
Over the past 5 years, Pacira BioSciences' Change in Inventory peaked at $14.4 million during Q2 2025, and registered a low of -$7.6 million during Q1 2024.
Its 3-year average for Change in Inventory is $5.6 million, with a median of $7.8 million in 2023.
The largest annual percentage gain for Pacira BioSciences' Change in Inventory in the last 5 years was 11,988.37% (2022), contrasted with its biggest fall of 567.17% (2022).
Over the past 5 years, Pacira BioSciences' Change in Inventory (Quarterly) stood at $1.9 million in 2021, then plummeted by 138.54% to -$735,000 in 2022, then soared by 1,165.71% to $7.8 million in 2023, then surged by 71.29% to $13.4 million in 2024, then grew by 12.89% to $9.5 million in 2025.
Its last three reported values are $9.5 million in Q3 2025, $14.4 million for Q2 2025, and $8.5 million during Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value